StockWatch
·

Emcure Pharmaceuticals Ltd Q3 FY25 Results

EMCUREQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue2.0K2.0%
Total Income2.0K3.5%
Expenditure1.7K1.6%
PBT229.9215.9%
Net Profit156.0922.6%
OPM4.96%0.23pp
NPM7.94%1.95pp
EPS8.1221.4%
View full financials

Informational and educational content only. Not investment advice.